A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C
Clicks: 234
ID: 269612
2011
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
An SVR reduced mortality among patients infected with HCV of genotypes 1, 2, or 3 who were being treated by routine medical practice and had substantial comorbidities.| Reference Key |
li2011clinicala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Backus LI;Boothroyd DB;Phillips BR;Belperio P;Halloran J;Mole LA;; |
| Journal | clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association |
| Year | 2011 |
| DOI | DOI not found |
| URL | |
| Keywords |
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
u.s. gov't
non-p.h.s.
female
male
middle aged
United States
Survival Analysis
ribavirin / administration & dosage
viral load*
chronic / mortality*
antiviral agents / administration & dosage*
chronic / drug therapy
chronic / virology*
pmid:21397729
doi:10.1016/j.cgh.2011.03.004
lisa i backus
derek b boothroyd
larry a mole
hepacivirus / isolation & purification*
interferons / administration & dosage
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.